Akèy › Pirura Trombositopenik Idyopatik › Distrik Columbia › Washington
Etid klinik pou Pirura Trombositopenik Idyopatik nan Washington, DC
6 etid pou Pirura Trombositopenik Idyopatik ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Ap rekriteFaz 1/2
- MedStar Georgetown University Hospital, Washington D.C.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi lwen
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Ap rekriteFaz 2
- Georgetown University Medical Center, Washington D.C.
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
OM336 in Autoimmune Cytopenias
Ap rekriteFaz 1
- Medstar, Washington D.C.
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Georgetown University Hospital, Washington D.C.
Etid Pirura Trombositopenik Idyopatik nan lòt vil
- Los Angeles, CA7 etid
- Greenville, NC6 etid
- Boston, MA6 etid
- The Bronx, NY5 etid
- Durham, NC4 etid
- Rochester, MN4 etid
- Seattle, WA4 etid
- Houston, TX4 etid
- Portland, OR4 etid
- New Orleans, LA3 etid
- Cedar Rapids, IA3 etid
- New Haven, CT3 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.